BglII POLYMORPHISM IN ITGA2 GENE IN PATIENTS WITH DIABETIC RETINOPATHY IN THE KAZAKHSTAN POPULATION
Introduction. Currently, one in ten adult around the world suffers from diabetes. Diabetic retinopathy is the most common microvascular complications of type 2 diabetes and a leading cause of blindness in middle-aged people in many countries. Accelerated thrombus formation observed in diabetic patients is considered one of the main causes of vascular complications, including retinopathy. According to the literature, polymorphism in the α-subunit of the integrin receptor α2β1, which plays an important role in the initial stages of blood coagulation, may be a risk factor for the development of diabetic retinopathy.
Purpose: to examine the hypothesis that the BglII polymorphism in ITGA2 gene associated with a predisposition to retinopathy among patients with type 2 diabetes mellitus in the Kazakhstan population.
Materials and methodology. We compared allele and genotype frequencies between 94 diabetic retinopathy patients, 94 diabetic patients without retinopathy, and 51 healthy controls. Genotypes were determined by PCR-RFLP method.
Results. The genotype distribution in each studied group was compatible with Hardy-Weinberg expectations. The genotype and allele frequencies were not significantly different between diabetic patients with and without retinopathy. Instead, both groups of diabetic patients significantly differed in allele (P = 0.021 and 0.002, respectively) and genotype frequencies (P = 0.042 and 0.005, respectively) from healthy controls. The BglII- allele was significantly associated with diabetes, OR = 1.81 [95% CI: 1.09–2.99] for the diabetic retinopathy group, and OR = 2.24 [95% CI: 1.34–3.75] for the non-retinopathy diabetic group. The association was also observed in comparisons within the subset of Kazakhs.
Conclusions. In this paper, we have shown that BglII polymorphism in ITGA2 gene may be associated not only with diabetic retinopathy, but also with type 2 diabetes mellitus. According to our data, the risk allele for diabetes is the wild BglII- allele, and not the minor BglII+, which is considered as such for diabetic retinopathy.
Aizhan Magazova1,2, Yeldar Ashirbekov2, Arman Abaildayev2,
Kantemir Satken2, Altinay Balmukhanova3, Zhanay Akanov4,
Aigul Balmukhanova¹, Kamalidin Sharipov²
1 S. Asfendiyarov Kazakh national medical University, Almaty c., Republic of Kazakhstan;
2 M. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty c., Republic of Kazakhstan;
3 CityAl - Farabi Kazakh national university, Almaty c., Republic of Kazakhstan;
4 City Center for Diabetes "Medical Clinic AAA", Almaty c., Republic of Kazakhstan.
1. Afzal N., Imran M., Zafar A., Musawar A., Tahir R., Abbas S., Abbas A., Zaman S., Jahan S. Association of Alpha-2 Beta-1 Integrin Polymorphism with Retinopathy in Diabetic Patients // J Diabetes Metab. 2012. 3:9(09): 1000223.
2. Azmy R., Dawood A., Kilany A., El-Ghobashy Y., Ellakwa A.F., El-Daly M. Association analysis of genetic variations of eNOS and α2β1 integrin genes with type 2 diabetic retinopathy // Appl Clin Genet. 2012; 5: 55-65.
3. Burdon K.P., McComish B.J., Charlesworth J.C. Progress and challenges in genome-wide studies to understand the genetics of diabetic retinopathy // Ann Eye Sci. 2018. 3: 46.
4. Cepeda-Nieto A.C., Esquivel-Contreras M.T., Duran-Iñiguez F., Salinas-Santander M.A. et al. High prevalence of diabetic retinopathy and lack of association with integrin α2 gene polymorphisms in patients with type 2 diabetes from Northeastern Mexico // Exp Ther Med. 2015;10(2):435-444.
5. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group Diabetes 1997; 46(11): 1829‐1839.
6. Cole J.B., Florez J.C. Genetics of diabetes mellitus and diabetes complications // Nat Rev Nephrol. 2020. Jul.16(7):377-390.
7. Duh E.J., Sun J.K., Stitt A.W. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies // JCI Insight. 2017. 2(14):e93751.
8. Furihata K., Nugent D.J., Kunicki T.J. Influence of platelet collagen receptor polymorphisms on risk for arterial thrombosis // Arch Pathol Lab Med. 2002; 126(3): 305-9.
9. Gardner T.W., Sundstrom J.M. A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping // Vision Res. 2017. 139: 153‐160.
10. Hendrick A.M., Gibson M.V., Kulshreshtha A. Diabetic Retinopathy // Prim Care. 2015. Sep.42(3):451-64.
11. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: IDF; 2021. http://www.diabetesatlas.org (Дата обращения: 25.10.2021)
12. Iskhakova A.G., Toropovsky A.N., Zolotarev A.V., Pavlova O.N., Komarova M.V., Viktorov D.A. Analysis of the mutation frequency of the genes associated with diabetic retinopathy in the Volga region // Modern problems of science and education. 2019. 6: 109-109.
13. Jacquelin B., Tarantino M.D., Kritzik M., Rozenshteyn D., Koziol J.A., Nurden A.T., Kunicki T.J. Allele-dependent transcriptional regulation of the human integrin α2 gene // Blood. 2001. 97 (6): 1721–1726.
14. Jalel A., Midani F., Fredj S.H., Messaoud T., Hentati F., Soualmia H. Association of BglII Polymorphism in ITGA2 and (894G/T and -786T/C) Polymorphisms in eNOS Gene With Stroke Susceptibility in Tunisian Patients α2 Gene Polymorphism in α2β1 Integrin and eNOS Gene Variants and Stroke // Biol Res Nurs. 2021. 23(3):408-417.
15. Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies // Cardiovasc Diabetol. 2018. 17(1):121.
16. Klaassen I., Van Noorden C.J., Schlingemann R.O. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions // Prog Retin Eye Res. 2013; 34: 19‐48.
17. Kritzik M., Savage B., Nugent D.J., Santoso S., Ruggeri Z.M., Kunicki T.J. Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density // Blood. 1998; 92(7): 2382-8.
18. Kunicki T.J., Kritzik M., Annis D.S., Nugent D.J. Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence // Blood. 1997. 89(6):1939-43.
19. Li H., Louey J.W., Choy K.W., Liu D.T. et al. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes // Mol Vis. 2008. 14: 1698-704.
20. Matsubara Y., Murata M., Maruyama T., Handa M., Yamagata N., Watanabe G., Saruta T., Ikeda Y. Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen // Blood. 2000;95(5):1560-4.
21. Midani F., Ben Amor Z., El Afrit M.A., Kallel A., Feki M., Soualmia H. The Role of Genetic Variants (rs869109213 and rs2070744) Of the eNOS Gene and BglII in the α2 Subunit of the α2β1 Integrin Gene in Diabetic Retinopathy in a Tunisian Population // Semin Ophthalmol. 2019;34(5):365-374.
22. Murugesan N., Üstunkaya T., Feener E.P. Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint // Semin Thromb Hemost. 2015;41(6):659-64.
23. Petrovič M.G., Hawlina M., Peterlin B., Petrovič D. BglII gene polymorphism of the alpha2beta1 integrin gene is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes // J Hum Genet. 2003;48(9):457-460.
24. Rema M., Saravanan G., Deepa R., et al. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients // Diabet Med 2002. 19: 910-6.
25. Simó-Servat O., Hernández C., Simó R. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy // Mediators Inflamm. 2012. 2012:872978.
26. Stratmann B., Tschoepe D. Pathobiology and cell interactions of platelets in diabetes // Diab Vasc Dis Res. 2005. 2(1):16-23.
27. The jamovi project. Jamovi (Version 1.2) [Computer Software]. 2020. Retrieved from https://www.jamovi.org. (Дата обращения: 12.10.2020)
28. Wong T.Y., Cheung C.M., Larsen M., Sharma S., Simó R. Diabetic retinopathy // Nat Rev Dis Primers. 2016 Mar 17, 2:16012.
29. Zheng Y., Ley S.H., Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications // Nat Rev Endocrinol. 2018.14(2):88-98.
Number of Views: 147
Category of articles:
Original articles
Bibliography link
Magazova A., Ashirbekov Ye., Abaildayev A., Satken K.,Balmukhanova A., Akanov Zh., Balmukhanova A., Sharipov K. BglII polymorphism in ITGA2 gene in patients with diabetic retinopathy in the Kazakhstan population // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 2, pp. 63-70. doi 10.34689/SH.2022.24.2.008Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS